How have PRVCF shares performed in 2024?

PreveCeutical Medical's stock was trading at $0.0181 at the beginning of 2024. Since then, PRVCF stock has increased by 5.0% and is now trading at $0.0190. View the best growth stocks for 2024 here .

How do I buy shares of PreveCeutical Medical?

Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PRVCF

PreveCeutical Medical (PRVCF) Stock Price, News & Analysis

→ Nerd Investor Reveals Secret To Make Money With A.I. (From InvestorPlace) (Ad)

Free PRVCF Stock Alerts

$0.02

+0.00 (+4.40%)

(As of 04/15/2024 09:45 AM ET)

Compare

Today's Range: $0.0190
▼
$0.0190
50-Day Range: $0.0113
▼
$0.0195
52-Week Range: $0.01
▼
$0.03

Volume: 5,000 shs
Average Volume: 63,096 shs
Market Capitalization: $10.17 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Short Interest

Get PreveCeutical Medical alerts:

Ad InvestorPlace

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

About PreveCeutical Medical Stock (OTCMKTS:PRVCF)

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

PRVCF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PRVCF Stock News Headlines

March 15, 2024 | morningstar.com

PreveCeutical Medical Inc PRVCF

September 18, 2023 | finance.yahoo.com

PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

September 12, 2023 | finance.yahoo.com

PreveCeutical Showcases Dynamic Evolution in AI Strategy

June 28, 2023 | finance.yahoo.com

PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof

May 30, 2023 | finance.yahoo.com

PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update

April 24, 2023 | finance.yahoo.com

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

April 20, 2023 | finance.yahoo.com

PreveCeutical Medical Announces Live Interactive Q&A Video Conference

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

April 4, 2023 | finance.yahoo.com

PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain

March 20, 2023 | finance.yahoo.com

PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee

February 23, 2023 | seekingalpha.com

PRVCF PreveCeutical Medical Inc.

February 21, 2023 | finance.yahoo.com

Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors

February 7, 2023 | finance.yahoo.com

PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development

January 14, 2023 | msn.com

PreveCeutical, Endosane team up for sol-gel tech use in cannabis therapy

January 12, 2023 | finance.yahoo.com

PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

January 9, 2023 | finance.yahoo.com

PreveCeutical Signs Intercompany Sol-Gel License Agreement

November 23, 2022 | finance.yahoo.com

The Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest News

November 21, 2022 | finance.yahoo.com

PreveCeutical Files Application for D-amino Acid Peptides

November 12, 2022 | finanznachrichten.de

PreveCeutical Medical Inc.: PreveCeutical Announces Conversion of Debt

November 12, 2022 | finance.yahoo.com

PreveCeutical Announces Conversion of Debt

October 20, 2022 | finance.yahoo.com

Appointment of Kathleen Rotika to PreveCeutical's Board of Directors

September 17, 2022 | finance.yahoo.com

PreveCeutical Announces Resignation of Board of Director Member

September 6, 2022 | finance.yahoo.com

Appointment of Sachin Nanavati to PreveCeutical's Board of Directors

May 27, 2022 | finance.yahoo.com

PreveCeutical Announces Change in Directors and Investor Awareness Services

May 9, 2022 | finance.yahoo.com

Article Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of Pharmacology

November 29, 2021 | finance.yahoo.com

PreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral Use

See More Headlines

Receive PRVCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Private households
Sub-Industry: N/A
Current Symbol: OTCMKTS:PRVCF
CUSIP: N/A
CIK: N/A
Web: www.preveceutical.com
Phone: (604) 416-7777
Fax: 778-945-6290
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,140,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -272.69%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.02
Quick Ratio: 0.02

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.01) per share
Price / Book: -1.90

Miscellaneous

Outstanding Shares: 535,300,000
Free Float: N/A
Market Cap: $10.17 million
Optionable: Not Optionable
Beta: 0.73

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Stephen Van Deventer (Age 55)
Chairman, CEO & CFO
Comp: $90.68k
Dr. Makarand Jawadekar Ph.D. (Age 73)
Chief Science Officer, President & Director
Comp: $55.35k
Mr. Shawn Sadler
Head of Artificial Intelligence

Key Competitors

View All Competitors

PRVCF Stock Analysis - Frequently Asked Questions

How have PRVCF shares performed in 2024?: PreveCeutical Medical's stock was trading at $0.0181 at the beginning of 2024. Since then, PRVCF stock has increased by 5.0% and is now trading at $0.0190.
View the best growth stocks for 2024 here.
How do I buy shares of PreveCeutical Medical?: Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PRVCF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial